88 related articles for article (PubMed ID: 7040018)
1. Sulindac: therapeutic implications of the prodrug/pharmacophore equilibrium.
Duggan DE
Drug Metab Rev; 1981; 12(2):325-37. PubMed ID: 7040018
[TBL] [Abstract][Full Text] [Related]
2. Kinetics of the tissue distributions of sulindac and metabolites. Relevance to sites and rates of bioactivation.
Duggan DE; Hooke KF; Hwang SS
Drug Metab Dispos; 1980; 8(4):241-6. PubMed ID: 6105058
[TBL] [Abstract][Full Text] [Related]
3. Biotransformation of sulindac in end-stage renal disease.
Gibson TP; Dobrinska MR; Lin JH; Entwistle LA; Davies RO
Clin Pharmacol Ther; 1987 Jul; 42(1):82-8. PubMed ID: 3595070
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of sulindac metabolism by dimethyl sulfoxide in the rat.
Swanson BN; Mojaverian P; Boppana VK
J Toxicol Environ Health; 1983; 12(2-3):213-22. PubMed ID: 6655731
[TBL] [Abstract][Full Text] [Related]
5. Effect of dimethyl sulfoxide on sulindac disposition in rats.
Swanson BN; Mojaverian P; Boppana VK; Dudash MR
Drug Metab Dispos; 1981; 9(6):499-502. PubMed ID: 6120805
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of graded oral doses of sulindac in man.
Mattila J; Mäntylä R; Vuorela A; Lamminsivu U; Männistö P
Arzneimittelforschung; 1984; 34(2):226-9. PubMed ID: 6539116
[TBL] [Abstract][Full Text] [Related]
7. Effect of uremia and anephric state on the pharmacokinetics of sulindac and its metabolites in rats. I. An application of pharmacokinetic model for reversible metabolism.
Lin JH; Yeh KC; Duggan DE
Drug Metab Dispos; 1985; 13(5):602-7. PubMed ID: 2865111
[TBL] [Abstract][Full Text] [Related]
8. Dimethyl sulfoxide inhibits bioactivation of sulindac.
Swanson BN; Boppana VK; Vlasses PH; Rotmensch HH; Ferguson RK
J Lab Clin Med; 1983 Jul; 102(1):95-101. PubMed ID: 6854139
[TBL] [Abstract][Full Text] [Related]
9. Identification of the biologically active form of sulindac.
Duggan DE; Hooke KF; Risley EA; Shen TY; Arman CG
J Pharmacol Exp Ther; 1977 Apr; 201(1):8-13. PubMed ID: 850147
[TBL] [Abstract][Full Text] [Related]
10. Renal metabolism of sulindac: functional implications.
Miller MJ; Bednar MM; McGiff JC
J Pharmacol Exp Ther; 1984 Nov; 231(2):449-56. PubMed ID: 6436473
[TBL] [Abstract][Full Text] [Related]
11. Sulfoxide reduction. In vitro reduction of sulindac by rat hepatic cytosolic enzymes.
Ratnayake JH; Hanna PE; Anders MW; Duggan DE
Drug Metab Dispos; 1981; 9(2):85-7. PubMed ID: 6113122
[TBL] [Abstract][Full Text] [Related]
12. Enterohepatic circulation of sulindac and metabolites.
Dujovne CA; Pitterman A; Vincek WC; Dobrinska MR; Davies RO; Duggan DE
Clin Pharmacol Ther; 1983 Feb; 33(2):172-7. PubMed ID: 6822030
[TBL] [Abstract][Full Text] [Related]
13. Thioredoxin-dependent sulfoxide reduction by rat renal cytosol.
Anders MW; Ratnayake JH; Hanna PE; Fuchs JA
Drug Metab Dispos; 1981; 9(4):307-10. PubMed ID: 6114827
[TBL] [Abstract][Full Text] [Related]
14. Biliary secretion of sulindac and metabolites in man.
Dobrinska MR; Furst DE; Spiegel T; Vincek WC; Tompkins R; Duggan DE; Davies RO; Paulus HE
Biopharm Drug Dispos; 1983; 4(4):347-58. PubMed ID: 6661513
[TBL] [Abstract][Full Text] [Related]
15. Sulindac metabolism: the importance of an intact colon.
Strong HA; Warner NJ; Renwick AG; George CF
Clin Pharmacol Ther; 1985 Oct; 38(4):387-93. PubMed ID: 4042521
[TBL] [Abstract][Full Text] [Related]
16. Effects of age and disease on the pharmacokinetics and pharmacodynamics of sulindac.
Sitar DS; Owen JA; MacDougall B; Hunter T; Mitenko PA
Clin Pharmacol Ther; 1985 Aug; 38(2):228-34. PubMed ID: 4017423
[TBL] [Abstract][Full Text] [Related]
17. Sulfone metabolite of sulindac inhibits mammary carcinogenesis.
Thompson HJ; Jiang C; Lu J; Mehta RG; Piazza GA; Paranka NS; Pamukcu R; Ahnen DJ
Cancer Res; 1997 Jan; 57(2):267-71. PubMed ID: 9000566
[TBL] [Abstract][Full Text] [Related]
18. In vitro metabolism of sulindac and sulindac sulfide: enzymatic formation of sulfoxide and sulfone.
Kitamura S; Tatsumi K
Jpn J Pharmacol; 1982 Oct; 32(5):833-8. PubMed ID: 7176218
[TBL] [Abstract][Full Text] [Related]
19. A kinetic study of sulindac in the elderly.
Bayley N; Warne RW; Moulds RF; Bury RW
Aust N Z J Med; 1987 Feb; 17(1):39-42. PubMed ID: 3476045
[TBL] [Abstract][Full Text] [Related]
20. Ibuprofen and sulindac kinetics in alcoholic liver disease.
Juhl RP; Van Thiel DH; Dittert LW; Albert KS; Smith RB
Clin Pharmacol Ther; 1983 Jul; 34(1):104-9. PubMed ID: 6861431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
